Tamoxifen
Brand names
- Alpha-Tamoxifen
- Apo-Tamox
- Dom-Tamoxifen
- Gen-Tamoxifen
- Nolvadex
- Nolvadex-D
- Novo-Tamoxifen
- PMS-Tamoxifen
- Tamofen
- Tamone
Usage
To treat breast cancer that is
estrogen-receptor positive.
How it works
Tamoxifen blocks the effects
of the hormone estrogen
on certain organs in the
body. Because the growth
of some types of breast
cancer is stimulated by
estrogen, tamoxifen interferes with the growth of
such tumors.
Side effects
- Serious
- Endometrial cancer (menstrual irregularities, abnormal nonmenstrual vaginal bleeding, changes in vaginal
discharge, pelvic pain or pressure); deep vein thrombosis and
pulmonary embolism (pain or swelling in legs, shortness of
breath, sudden chest pain, coughing up
blood);
cataracts;
new breast lumps; confusion, weakness, or drowsiness;
yellowish tinge to eyes or skin.
- Common
- Hot flashes, weight gain,
nausea, vomiting.
- Less common
- Bone pain, headache,
visual disturbances, skin dryness or
rash, changes in menstrual period, vaginal discharge,
itching in genital area of women,
depression,
impotence or
decreased sexual interest in men. Other side effects include
high blood calcium levels and liver dysfunction; such
problems can be detected by your doctor.
Possible interactions
- Other medicaments:
The following medicaments may decrease the effects of tamoxifen:
- estrogens.
- oral contraceptives (those that contain estrogens).
Tamoxifen taken concurrently with:
- allopurinol (Zyloprim) may worsen allopurinol toxicity to the liver.
- clopidogrel (Plavix) may result in higher than expected tamoxifen levels;
no reports of adverse effects from this reaction have been made, but caution
is advised.
- cyclophosphamide (Cytoxan) may increase blood clot (thromboembolism)
risk.
- cyclosporine (Sandimmune) may increase cyclosporine levels and cause
toxicity.
- medicines that inhibit CYP2C9 (such as fluconazole,
fluvastatin and zafirlukast) may lead to increased tamoxifen levels.
- methotrexate (Mexate, Rheumatrex) may increase blood clot
(thromboembolism) risk.
- mitomycin will cause increased risk of hemolytic uremic syndrome.
- pneumococcal and perhaps other vaccines will blunt the vaccine's immune
response.
- ritonavir (Norvir) and perhaps other protease inhibitors
may lead to toxicity.
- warfarin (Coumadin) presents an increased risk of
bleeding; increased
frequency of INR (prothrombin time or protime) testing is needed.
- Herbal medicines or minerals:
- Some patients use Echinacea to attempt to boost
their immune systems. Unfortunately, use of
Echinacea is not recommended
in people with damaged immune systems. This herb may also actually
weaken any immune system if it is used too often or for too long a time.
- .
|